| Appropriateness of cardiovascular disease prevention recommendations obtained from a popular online chat-based artificial intelligence model A Sarraju, D Bruemmer, E Van Iterson, L Cho, F Rodriguez, L Laffin Jama 329 (10), 842-844, 2023 | 237 | 2023 |
| Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors M Brudner, M Karpel, C Lear, L Chen, LM Yantosca, C Scully, A Sarraju, ... PloS one 8 (4), e60838, 2013 | 96 | 2013 |
| Finding missed cases of familial hypercholesterolemia in health systems using machine learning JM Banda, A Sarraju, F Abbasi, J Parizo, M Pariani, H Ison, E Briskin, ... NPJ digital medicine 2 (1), 23, 2019 | 72 | 2019 |
| Machine learning and atherosclerotic cardiovascular disease risk prediction in a multi-ethnic population A Ward, A Sarraju, S Chung, J Li, R Harrington, P Heidenreich, ... NPJ digital medicine 3 (1), 125, 2020 | 58 | 2020 |
| Genetic testing and risk scores: impact on familial hypercholesterolemia A Sarraju, JW Knowles Frontiers in Cardiovascular Medicine 6, 5, 2019 | 45 | 2019 |
| Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure … A Sarraju, JW Li, CP Cannon, TI Chang, R Agarwal, G Bakris, ... American heart journal 233, 141-148, 2021 | 42 | 2021 |
| Dietary patterns and long-term survival: a retrospective study of healthy primary care patients NS Shah, D Leonard, CE Finley, F Rodriguez, A Sarraju, CE Barlow, ... The American journal of medicine 131 (1), 48-55, 2018 | 31 | 2018 |
| Tailoring Encodable Lanthanide‐Binding Tags as MRI Contrast Agents KD Daughtry, LJ Martin, A Sarraju, B Imperiali, KN Allen ChemBioChem 13 (17), 2567-2574, 2012 | 30 | 2012 |
| COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohort A Ward, A Sarraju, D Lee, K Bhasin, S Gad, R Beetel, S Chang, ... PLoS One 17 (1), e0261786, 2022 | 28 | 2022 |
| Under-reporting and under-representation of racial/ethnic minorities in major atrial fibrillation clinical trials A Sarraju, DJ Maron, F Rodriguez Clinical Electrophysiology 6 (6), 739-741, 2020 | 25 | 2020 |
| Metabolic markers to predict incident diabetes mellitus in statin-treated patients (from the treating to new targets and the stroke prevention by aggressive reduction in … P Kohli, JW Knowles, A Sarraju, DD Waters, G Reaven The American journal of cardiology 118 (9), 1275-1281, 2016 | 19 | 2016 |
| Artificial intelligence–enabled analysis of statin-related topics and sentiments on social media S Somani, MM van Buchem, A Sarraju, T Hernandez-Boussard, ... JAMA Network Open 6 (4), e239747-e239747, 2023 | 15 | 2023 |
| Using deep learning-based natural language processing to identify reasons for statin nonuse in patients with atherosclerotic cardiovascular disease A Sarraju, J Coquet, A Zammit, A Chan, S Ngo, T Hernandez-Boussard, ... Communications Medicine 2 (1), 88, 2022 | 14 | 2022 |
| Online patient education materials related to lipoprotein (a): readability assessment K Pearson, S Ngo, E Ekpo, A Sarraju, G Baird, J Knowles, F Rodriguez Journal of Medical Internet Research 24 (1), e31284, 2022 | 14 | 2022 |
| Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients A Sarraju, A Ward, S Chung, J Li, D Scheinker, F Rodríguez Open Heart 8 (2), e001802, 2021 | 14 | 2021 |
| Health disparities across the continuum of ASCVD risk A Devareddy, A Sarraju, F Rodriguez Current cardiology reports 24 (9), 1129-1137, 2022 | 12 | 2022 |
| Pandemic-proof recruitment and engagement in a fully decentralized trial in atrial fibrillation patients (DeTAP) A Sarraju, C Seninger, V Parameswaran, C Petlura, T Bazouzi, K Josan, ... NPJ digital medicine 5 (1), 80, 2022 | 12 | 2022 |
| Statin use in older adults with stable atherosclerotic cardiovascular disease G Spencer‐Bonilla, S Chung, A Sarraju, P Heidenreich, L Palaniappan, ... Journal of the American Geriatrics Society 69 (4), 979-985, 2021 | 12 | 2021 |
| canagliflozin (Cana) reduces cardiovascular (Cv) and renal events independent of baseline heart failure (Hf): A credence secondary analysis A Sarraju, JW Li, CP Cannon, TI Chang, R Agarwal, GL Bakris, ... Journal of the American College of Cardiology 75 (11_Supplement_1), 1018-1018, 2020 | 11 | 2020 |
| Diverse racial/ethnic group underreporting and underrepresentation in high-impact cholesterol treatment trials A Sarraju, A Valencia, JW Knowles, DJ Maron, F Rodriguez Circulation 143 (24), 2409-2411, 2021 | 9 | 2021 |
